rs375051705

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_015102.5(NPHP4):​c.1490C>G​(p.Pro497Arg) variant causes a missense change. The variant allele was found at a frequency of 0.0025 in 1,601,166 control chromosomes in the GnomAD database, including 124 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. P497T) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.0014 ( 2 hom., cov: 33)
Exomes 𝑓: 0.0026 ( 122 hom. )

Consequence

NPHP4
NM_015102.5 missense

Scores

7
11

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:6

Conservation

PhyloP100: 4.56

Publications

4 publications found
Variant links:
Genes affected
NPHP4 (HGNC:19104): (nephrocystin 4) This gene encodes a protein involved in renal tubular development and function. This protein interacts with nephrocystin, and belongs to a multifunctional complex that is localized to actin- and microtubule-based structures. Mutations in this gene are associated with nephronophthisis type 4, a renal disease, and with Senior-Loken syndrome type 4, a combination of nephronophthisis and retinitis pigmentosa. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Apr 2014]
NPHP4 Gene-Disease associations (from GenCC):
  • nephronophthisis 4
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Ambry Genetics, ClinGen, Labcorp Genetics (formerly Invitae), G2P
  • Senior-Loken syndrome 4
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), G2P
  • nephronophthisis 1
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • Senior-Loken syndrome
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0061025918).
BP6
Variant 1-5909165-G-C is Benign according to our data. Variant chr1-5909165-G-C is described in ClinVar as Benign. ClinVar VariationId is 215518.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population sas. GnomAd4 allele frequency = 0.00139 (212/152324) while in subpopulation SAS AF = 0.042 (203/4830). AF 95% confidence interval is 0.0373. There are 2 homozygotes in GnomAd4. There are 160 alleles in the male GnomAd4 subpopulation. Median coverage is 33. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 2 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
NPHP4NM_015102.5 linkc.1490C>G p.Pro497Arg missense_variant Exon 12 of 30 ENST00000378156.9 NP_055917.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
NPHP4ENST00000378156.9 linkc.1490C>G p.Pro497Arg missense_variant Exon 12 of 30 1 NM_015102.5 ENSP00000367398.4 O75161-1
NPHP4ENST00000489180.6 linkn.1490C>G non_coding_transcript_exon_variant Exon 12 of 33 2 ENSP00000423747.1 O75161-2
NPHP4ENST00000378169.7 linkn.*516-3385C>G intron_variant Intron 10 of 26 1 ENSP00000367411.3 D6RA06

Frequencies

GnomAD3 genomes
AF:
0.00141
AC:
215
AN:
152206
Hom.:
2
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.000121
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0000654
Gnomad ASJ
AF:
0.000288
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.0426
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000147
Gnomad OTH
AF:
0.000478
GnomAD2 exomes
AF:
0.00527
AC:
1188
AN:
225450
AF XY:
0.00694
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.0000620
Gnomad ASJ exome
AF:
0.000208
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.0000533
Gnomad NFE exome
AF:
0.0000588
Gnomad OTH exome
AF:
0.00233
GnomAD4 exome
AF:
0.00261
AC:
3785
AN:
1448842
Hom.:
122
Cov.:
31
AF XY:
0.00374
AC XY:
2693
AN XY:
719118
show subpopulations
African (AFR)
AF:
0.000120
AC:
4
AN:
33294
American (AMR)
AF:
0.0000699
AC:
3
AN:
42940
Ashkenazi Jewish (ASJ)
AF:
0.000309
AC:
8
AN:
25860
East Asian (EAS)
AF:
0.0000509
AC:
2
AN:
39262
South Asian (SAS)
AF:
0.0429
AC:
3575
AN:
83248
European-Finnish (FIN)
AF:
0.0000381
AC:
2
AN:
52476
Middle Eastern (MID)
AF:
0.00191
AC:
11
AN:
5752
European-Non Finnish (NFE)
AF:
0.0000335
AC:
37
AN:
1106102
Other (OTH)
AF:
0.00239
AC:
143
AN:
59908
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.487
Heterozygous variant carriers
0
214
429
643
858
1072
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
46
92
138
184
230
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00139
AC:
212
AN:
152324
Hom.:
2
Cov.:
33
AF XY:
0.00215
AC XY:
160
AN XY:
74494
show subpopulations
African (AFR)
AF:
0.000120
AC:
5
AN:
41568
American (AMR)
AF:
0.0000653
AC:
1
AN:
15306
Ashkenazi Jewish (ASJ)
AF:
0.000288
AC:
1
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5180
South Asian (SAS)
AF:
0.0420
AC:
203
AN:
4830
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10632
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.0000147
AC:
1
AN:
68016
Other (OTH)
AF:
0.000473
AC:
1
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.497
Heterozygous variant carriers
0
12
23
35
46
58
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000336
Hom.:
0
Bravo
AF:
0.000227
TwinsUK
AF:
0.00
AC:
0
ALSPAC
AF:
0.000519
AC:
2
ExAC
AF:
0.00569
AC:
686
Asia WGS
AF:
0.0160
AC:
57
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:6
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:2
-
Clinical Genetics, Academic Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

-
Genome Diagnostics Laboratory, University Medical Center Utrecht
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Senior-Loken syndrome 4 Benign:1
Jan 12, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Nephronophthisis Benign:1
Jan 06, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:1
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Nephronophthisis 4 Benign:1
Jan 12, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.18
BayesDel_addAF
Benign
-0.29
T
BayesDel_noAF
Benign
-0.16
CADD
Uncertain
25
DANN
Uncertain
1.0
DEOGEN2
Benign
0.18
T;.
Eigen
Uncertain
0.30
Eigen_PC
Benign
0.18
FATHMM_MKL
Uncertain
0.76
D
LIST_S2
Benign
0.83
T;T
MetaRNN
Benign
0.0061
T;T
MetaSVM
Uncertain
-0.083
T
MutationAssessor
Uncertain
2.7
M;M
PhyloP100
4.6
PrimateAI
Uncertain
0.65
T
PROVEAN
Benign
-1.9
N;.
REVEL
Benign
0.26
Sift
Uncertain
0.016
D;.
Sift4G
Benign
0.18
T;T
Polyphen
1.0
D;.
Vest4
0.42
MutPred
0.22
Gain of MoRF binding (P = 0.005);Gain of MoRF binding (P = 0.005);
MVP
0.93
MPC
0.39
ClinPred
0.038
T
GERP RS
3.5
Varity_R
0.085
gMVP
0.40
Mutation Taster
=97/3
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.020
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs375051705; hg19: chr1-5969225; API